Article
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Journal of the National Cancer Institute - 6 Jan 1993
Sarkis A S, Dalbagni G, Cordon-Cardo C, Zhang Z F, Sheinfeld J, Fair W R, Herr H W, Reuter V E
Abstract excerpt
BACKGROUND: Approximately one third of the patients with superficially infiltrative transitional cell (T1-TNM pathological staging system) bladder carcinoma who are treated with transurethral resection alone have disease progression. Despite precise pathologic staging and grading, clinical outcome in these patients is not predictable. Recent reports reveal that mutations of the p53 tumor suppressor gene (also...
Topics
- Adult
- Aged
- Aged, 80 and over
- Analysis of Variance
- Biomarkers, Tumor
- Carcinoma in Situ
- Carcinoma, Transitional Cell
- Female
- Genes, p53
- Humans
- Immunoenzyme Techniques
